Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma

NCT07213934 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions

RADIATION: Proton therapy
DRUG: Pembrolizumab

Sponsor

University of Cincinnati